Assessing PA-824 for Tuberculosis (the APT Trial)

NCT02256696 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

157

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Tuberculosis

Interventions

DRUG: PA-824
DRUG: Rifampin
DRUG: Rifabutin
DRUG: Pyrazinamide
DRUG: Ethambutol
DRUG: Isoniazid

Sponsor

Johns Hopkins University

Collaborators

[object Object]